The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Leronlimab in combination with trifluridine/tipiracil (TAS-102) plus bevacizumab for patients with refractory metastatic colorectal cancer (mCRC): The phase 2 CLOVER study.
 
Pashtoon Kasi
Leadership - Precision Biosensors
Stock and Other Ownership Interests - Elicio Therapeutics
Consulting or Advisory Role - Agenus; Astellas Pharma; Bayer; BeiGene; BostonGene; BostonGene; Daiichi Sankyo/Astra Zeneca; Delcath Systems; Eisai; Elicio Therapeutics; Exact Sciences; Foundation Medicine; Guardant Health; Illumina; Ipsen (Inst); Lilly; MSD Oncology; Natera; NeoGenomics Laboratories; QED Therapeutics; Regeneron; SAGA Diagnostics; Seagen; SERVIER; Taiho Oncology; Taiho Pharmaceutical (Inst); Tempus; Xilio Therapeutics
Research Funding - Advanced Accelerator Applications (Inst); Agenus (Inst); Boston Scientific (Inst); Merck (Inst); Tersera (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Ari Baron
Speakers' Bureau - Abbvie; Astellas Pharma; Bristol-Myers Squibb
 
Arvind Chaudhry
Stock and Other Ownership Interests - Immunomedics; Novartis
Consulting or Advisory Role - Exelixis
Research Funding - Abbvie; Amgen; Arcus Biosciences; AstraZeneca; BeOne Medicines; CytoDyn; Daiichi Sankyo; DualityBio; Exelixis; Janssen
 
Laura Tenner
Consulting or Advisory Role - Curio Science
Travel, Accommodations, Expenses - Curio Science
 
Namrata Vijayvergia
Honoraria - Guidepoint Global
Consulting or Advisory Role - Boehringer Ingelheim; Exelixis; Gilead Sciences; Jazz Pharmaceuticals; Pfizer; RayzeBio
Research Funding - Bristol-Myers Squibb/Medarex (Inst); ITM Isotope Technologies Munich (Inst); Oryzon Genomics (Inst); Puma Biotechnology (Inst); Zymeworks (Inst)
 
Michael Driscoll
No Relationships to Disclose
 
Daniel Adams
Employment - Creatv MicroTech
Leadership - Creatv MicroTech
Stock and Other Ownership Interests - Creatv MicroTech
Patents, Royalties, Other Intellectual Property - Inventor and co-inventor on multiple US patents
(OPTIONAL) Uncompensated Relationships - Briacell; Cytodyn
 
Alexis Duffy
Employment - Creatv MicroTech, Inc
Travel, Accommodations, Expenses - Creatv MicroTech, Inc
 
Hallgeir Rui
Stock and Other Ownership Interests - Advantex BioReagents; iHG Biosciences; miRoncol Diagnostics
Consulting or Advisory Role - CytoDyn; miRoncol Diagnostics
Expert Testimony - Janssen
 
Richard Pestell
Leadership - EcoGenome LLC.; ioROC Therapeutics LLC.; LightSeed LLC.; Shenandoah Pharmaceuticals LLC.; StromaGenesis LLC.
Stock and Other Ownership Interests - CytoDyn; EcoGenome LLC.; ioROC Therapeutics LLC.; LightSeed LLC.; Shenandoah Pharmaceuticals LLC.; StromaGenesis LLC.
Consulting or Advisory Role - CytoDyn
Research Funding - CytoDyn
Patents, Royalties, Other Intellectual Property - EcoGenome LLC.; ioROC Therapeutics LLC.; LightSeed LLC.; Shenandoah Pharmaceuticals LLC.; StromaGenesis LLC.
 
Patrick Vittner
Employment - CytoDyn; Merck; Viridian Therapeutics
 
Joseph Meidling
Employment - CytoDyn
Stock and Other Ownership Interests - CytoDyn
 
Jacob Lalezari
Employment - CytoDyn
Leadership - CytoDyn
Stock and Other Ownership Interests - CytoDyn